Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
December 10, 2021updated 11 Jan 2022 8:05pm

Industrial automation innovation among pharmaceutical industry companies rebounded in the last quarter

Johnson & Johnson was the top industrial automation innovator in the pharmaceutical sector in the last quarter

By Michael Goodier

Research and innovation in industrial automation in the pharmaceutical sector has rebounded in the last quarter.

The most recent figures show that the number of industrial automation patent applications in the industry stood at 100 in the three months ending October – down from 114 over the same period last year.

Figures for patent grants related to industrial automation followed a different pattern to filings – stagnating from 65 in the three months ending October last year to 65 this year.

The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.

Industrial automation is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

The figures also provide an insight into the largest innovators in the sector.

Johnson & Johnson was the top industrial automation innovator in the pharmaceutical sector in the last quarter. The company, which has its headquarters in the United States, filed 96 industrial automation related patents in the three months ending October. That was down from 117 over the same period last year.

It was followed by the United States based Thermo Fisher Scientific Inc with 51 industrial automation patent applications, Germany based Sartorius AG (21 applications), and Switzerland based F. Hoffmann-La Roche Ltd (18 applications).

Thermo Fisher Scientific Inc has recently ramped up R&D in industrial automation. It saw growth of 29.4% in related patent applications in the three months ending October compared to the same period last year - the highest percentage growth out of all companies tracked with more than 10 quarterly patents in the pharmaceutical sector.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy